PAPER Piemontese L

An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions.

Neural Regen Res. 2019 Jan;14(1):43-45. PubMed: 30531068

PAPER Martinez B, Peplow PV

MicroRNAs as diagnostic and therapeutic tools for Alzheimer's disease: advances and limitations.

Neural Regen Res. 2019 Feb;14(2):242-255. PubMed: 30531004

PAPER Pan KY, Xu W, Mangialasche F, Dekhtyar S, Fratiglioni L, Wang HX

Working Life Psychosocial Conditions in Relation to Late-Life Cognitive Decline: A Population-Based Cohort Study.

J Alzheimers Dis. 2019;67(1):315-325. PubMed: 30530976

PAPER Farlow MR, Thompson RE, Wei LJ, Tuchman AJ, Grenier E, Crockford D, Wilke S, Benison J, Alkon DL

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.

J Alzheimers Dis. 2019;67(2):555-570. PubMed: 30530975

PAPER Bonvicini C, Scassellati C, Benussi L, Di Maria E, Maj C, Ciani M, Fostinelli S, Mega A, Bocchetta M, Lanzi G, Giacopuzzi E, Ferraboli S, Pievani M, Fedi V, Defanti CA, Giliani S, Alzheimer’s Disease Neuroimaging Initiative, Frisoni GB, Ghidoni R, Gennarelli M

Next Generation Sequencing Analysis in Early Onset Dementia Patients.

J Alzheimers Dis. 2019;67(1):243-256. PubMed: 30530974

PAPER Medeiros AM, Silva RH

Sex Differences in Alzheimer's Disease: Where Do We Stand?

J Alzheimers Dis. 2019;67(1):35-60. PubMed: 30530972

PAPER Torrealba E, Garcia-Morales P, Cejudo JC, Diaz M, Rodriguez-Esparragon F, Fabre O, Mesa-Herrera F, Marin R, Sanchez-Garcia F, Rodriguez-Perez A, Gramunt N

In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease.

J Alzheimers Dis. 2019;67(1):265-277. PubMed: 30530971

PAPER Liu X, Hou D, Lin F, Luo J, Xie J, Wang Y, Tian Y

The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.

Rev Neurosci. 2018 Dec 10; PubMed: 30530893

PAPER Hara Y, McKeehan N, Fillit HM

Translating the biology of aging into novel therapeutics for Alzheimer disease.

Neurology. 2019 Jan 8;92(2):84-93. Epub 2018 Dec 7 PubMed: 30530798

PAPER Jiang P, Wang X, Li Q, Jin L, Li S

Correlation-aware Sparse and Low-rank Constrained Multi-task Learning for Longitudinal Analysis of Alzheimer's Disease.

IEEE J Biomed Health Inform. 2018 Dec 6; PubMed: 30530378

PAPER Wang P, Liu Y, Shen D

Flexible Locally Weighted Penalized Regression With Applications on Prediction of Alzheimer's Disease Neuroimaging Initiative's Clinical Scores.

IEEE Trans Med Imaging. 2019 Jun;38(6):1398-1408. Epub 2018 Dec 5 PubMed: 30530315

PAPER Cortes N, Sabogal-Guaqueta AM, Cardona-Gomez GP, Osorio E

Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer's model treated with Zephyranthes carinata alkaloids.

Biomed Pharmacother. 2019 Feb;110:482-492. Epub 2018 Dec 6 PubMed: 30530228

PAPER Bussy A, Snider BJ, Coble D, Xiong C, Fagan AM, Cruchaga C, Benzinger TL, Gordon BA, Hassenstab J, Bateman RJ, Morris JC, Dominantly Inherited Alzheimer Network

Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.

Neurobiol Aging. 2019 Mar;75:42-50. Epub 2018 Oct 13 PubMed: 30530186

PAPER Yazdani M, Edraki N, Badri R, Khoshneviszadeh M, Iraji A, Firuzi O

Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation.

Bioorg Chem. 2019 Mar;84:363-371. Epub 2018 Nov 29 PubMed: 30530107

PAPER Laskowska E, Kuczyńska-Wiśnik D, Lipińska B

Proteomic analysis of protein homeostasis and aggregation.

J Proteomics. 2019 Apr 30;198:98-112. Epub 2018 Dec 6 PubMed: 30529741